490 BioTech Focused on research solutions that save you time and money while providing the data you need to move your ideas into practice.
490 BioTech is a life sciences company that develops patent protected light-emitting (bioluminescent) human cell lines genetically programmed to ‘report’ on biological events or interactions that affect their metabolic status. The incorporation of these cell lines into cell culture and small animal preclinical efficacy/toxicity testing models is designed to accelerate the pace of new drug discovery and move drugs more rapidly and more effectively towards Phase I human testing with a reduced overall cost.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Dec 4, 2013 | Grant | $150K | 1 | National Science Foundation | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
National Science Foundation | Yes | Grant |